When a person experiences breathlessness at a high altitude of 3000 m, it is often due to altitude sickness, which can result from decreased atmospheric pressure and reduced oxygen availability. Management options for this situation typically focus on improving oxygen saturation and alleviating symptoms related to hypoxia.
Let's examine each option:
Given these explanations, intravenous digoxin is not appropriate for managing breathlessness at high altitudes related to altitude sickness. It does not address the underlying cause of the breathlessness, which is primarily due to hypoxia.
